There goals are an estimate based on the response from the FDA, they could have had more questions, which could delay the response.
Regen IPO was given out in anticipation of the FDA response and what progress is to come. The dates were just too coincidental for the Regen BioPharma IPO dates.
There will be some pullback as there always is, but if FDA approval is given, people will hold as they wait for FDA Orphan status. After that we have the IND approval for dCellVax, after that there will be probably more patents and then more IND's. My point is that, anyone selling off would be a fool, they're too many things going on in the coming months.